BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24722213)

  • 1. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
    Ock CY; Kim S; Keam B; Kim M; Kim TM; Kim JH; Jeon YK; Lee JS; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
    Oncotarget; 2016 Mar; 7(13):15901-14. PubMed ID: 26893364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.
    Psyrri A; Lee JW; Pectasides E; Vassilakopoulou M; Kosmidis EK; Burtness BA; Rimm DL; Wanebo HJ; Forastiere AA
    Clin Cancer Res; 2014 Jun; 20(11):3023-32. PubMed ID: 24700741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
    Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
    Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
    Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
    Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.
    Wolf GT; Winter W; Bellile E; Nguyen A; Donnelly CR; McHugh JB; Thomas D; Amlani L; Rozek L; Lei YL;
    Oral Oncol; 2018 Dec; 87():29-35. PubMed ID: 30527240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
    Baschnagel AM; Tonlaar N; Eskandari M; Kumar T; Williams L; Hanna A; Pruetz BL; Wilson GD
    J Oral Pathol Med; 2017 Mar; 46(3):208-213. PubMed ID: 27442811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.
    Jung AC; Ray AM; Ramolu L; Macabre C; Simon F; Noulet F; Blandin AF; Renner G; Lehmann M; Choulier L; Kessler H; Abecassis J; Dontenwill M; Martin S
    Oncotarget; 2015 Dec; 6(39):41884-901. PubMed ID: 26474461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
    Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
    Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
    Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
    Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
    Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
    Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
    Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
    Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.